Glucophage
NDC Package 0087-6064-13

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Glucophage is metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Marketed by Bristol-myers Squibb Company, this product is identified by NDC 0087-6064 and is authorized under FDA application NDA021202.

Identification & Billing

NDC Package Code
0087-6064-13
Package Description
100 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
0087-6064
11-Digit Billing Format
00087606413
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Glucophage XR
Dosage Form
-
Usage Information
Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Regulatory & Marketing

Labeler Name
Bristol-myers Squibb Company
FDA Application #
NDA021202
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-01-2009
End Marketing Date
04-30-2021
Listing Expiration
04-30-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0087-6064-13 identifies a specific commercial package of 100 tablet, extended release in 1 bottle of Glucophage XR, labeled by Bristol-myers Squibb Company. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bristol-myers Squibb Company on June 01, 2009. The current certification is valid through April 30, 2021.

What are the primary indications for this medication?

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

How is this Bristol-myers Squibb Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00087606413. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0087-6064-13
11-Digit CMS (5-4-2)
00087-6064-13

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.